Latest news for OncoSec Medical (OTC:ONCSQ) Stock

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

ONCOSEC MEDICAL INC NEW by OncoSec Medical Incorporated

OncoSec Medical Inc

News

IPOs

Reported Earlier, TEN Holdings Prices $10M Initial Public Offering Of 1,667,000 Common Shares At $6/Share, Shares To Trade On NASDAQ Under "XHLD"

Earnings

Earnings Misses

Barclays Q4 2024 GAAP EPS $0.34 Misses $0.35 Estimate, Sales $8.927B Up From $6.950B YoY

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index in the &#8220;Fear&#8221; zone on Wednesday.
U.S. stocks settled mostly lower on Wednesday, with the Dow Jones index falling more than 200 points during the session following the release of inflation data.
The headline CPI rose 3% year over year in January, surpassing both December&#8217;s 2.9% reading and economist forecasts of 2.9%. On a monthly basis, inflation increased 0.5%, outpacing expectations of 0.3% and accelerating from December&#8217;s 0.4% gain. This marked the fastest monthly inflation rate since August 2023.
Shares of some megacap tech stocks, including Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) settled lower on Wednesday. However, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares jumped more than 2% during the session after the electric vehicle maker tumbled 6.3% on Tuesday, reaching oversold levels and extending its losing streak to five consecutive sessions.
CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) shares surged around 15% on Wednesday after the company reported better-than-expected results for its fourth quarter.
Most sectors on the S&amp;P 500 closed on a negative note, with materials, energy, and real estate stocks recording losses on Wednesday. However, consumer staples and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 225 points to 44,368.56 on Wednesday. The S&amp;P 500 fell 0.27% to 6,051.97, while the Nasdaq Composite rose 0.03% at 19,649.95 during Wednesday's session.
Investors are awaiting earnings results from Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), and Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) today.
What Is CNN Business Fear &amp; Greed Index?
At a current reading of 43.8, the index remained in the &#8220;Fear&#8221; zone on Wednesday, versus a prior reading of 44.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43656665/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-telecom-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech &amp; Telecom Stocks With Over 3% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

AMZN

COIN

GEHC

GOOG

GOOGL

TSLA

Dow Dips More Than 200 Points Following Inflation Report, Megacap Tech Stocks Edge Lower: Greed Index In 'Fear' Zone

Reported Earlier, Bell Prices $1B And $1.25B Fixed-to-Fixed Rate Notes, Offering Interest Resets Every Five Years

Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/zbra/earnings">opening bell, on Thursday, Feb. 13, 2025.</a>
Analysts expect the Lincolnshire, Illinois-based company to report quarterly earnings at $3.94 per share, up from $1.71 per share in the year-ago period. Zebra Technologies projects quarterly revenue of $1.32 billion, compared to $1.01 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Jan. 7, Zebra Technologies announced plans to acquire Photoneo, a leading developer and manufacturer of 3D machine vision solutions.
Zebra Technologies shares fell 0.4% to close at $352.92 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/GBX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Truist Securities analyst Jamie Cook maintained a Hold rating and raised the price target from $408 to $409 on Jan. 16, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating and increased the price target from $400 to $427 on Dec. 17, 2024. This analyst has an accuracy rate of 76%.</li>
<li>Barclays analyst Tim Long maintained an Equal-Weight rating and raised the price target from $347 to $407 on Oct. 31, 2024. This analyst has an accuracy rate of 74%.</li>
<li>TD Cowen analyst Joseph Giordano maintained a Buy rating and increased the price target from $380 to $425 on Oct. 30, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Baird analyst Richard Eastman maintained an Outperform rating and boosted the price target from $380 to $415 on Oct. 30, 2024. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying ZBRA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="626" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-1024x626.png" alt="" class="wp-image-780382" style="width:692px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-1024x626.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109-768x469.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13023754/image-109.png 1083w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43656665/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-telecom-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech &amp; Telecom Stocks With Over 3% Dividend Yields</a></li>
</ul>

Price Target

Analyst Ratings

ZBRA

Zebra Technologies Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Deere &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) to report quarterly earnings at $3.11 per share on revenue of $7.70 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Deere shares fell 0.1% to $476 in after-hours trading.</li>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) reported a fourth-quarter loss of 3 cents per share, down from earnings of 1 cent per share in the prior year's quarter. Quarterly revenue came in at $140.58 million, beating the $138.27 million analyst consensus estimate. Fastly expects first-quarter losses of between 9 cents and 5 cents per share, versus the loss of 1 cent estimate, and revenue in a range of $136 million to $140 million, versus the $137.05 million estimate. Fastly shares dipped 21.5% to $7.91 in the after-hours trading session.</li>
<li>Analysts are expecting GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) to post quarterly earnings at $1.26 per share on revenue of $5.33 billion. The company will release earnings before the markets open. GE HealthCare shares fell 0.1% to $85.82 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>HubSpot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) reported stronger-than-expected results for its fourth quarter. The company said it sees first-quarter revenue of between $697 million and $699 million, versus the $705.71 million estimate, and EPS of between $1.74 and $1.76, versus the $2.00 estimate. HubSpot shares gained 5% to $825.00 in the after-hours trading session.</li>
<li>Analysts expect Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) to post quarterly earnings at $1.81 per share on revenue of $1.83 billion after the closing bell. Coinbase shares gained 3% to $283.10 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43656665/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-telecom-stocks-with-over-3-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech &amp; Telecom Stocks With Over 3% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Long Ideas

FSLY

HUBS

Deere, GE HealthCare And 3 Stocks To Watch Heading Into Thursday

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is offering discounts up to $6000 on inventory <a href="https://www.benzinga.com/topic/cybertruck">Cybertrucks</a> in the U.S.
What Happened: The company is offering discounts up to $6000 on foundation series Cybertrucks and $5,100 on non-foundation series Cybertrucks in its inventory.
The offers apply to new 2024 model year vehicles.
In January, the company only offered discounts of <a href="https://www.benzinga.com/tech/25/01/43021093/tesla-offers-discounts-up-to-2000-on-new-inventory-cybertrucks">as much as $2000 on non-foundation series </a>Cybertrucks. 
Why It Matters:&nbsp;The Cybertruck is one of Tesla's more premium offerings. The vehicle starts at $79,990 for the base all-wheel drive variant and at $99,990 for the more premium Cyberbeast variant.
According to data from automotive research firm Kelley Blue Book, the Cybertruck was Tesla's third best-selling vehicle in the U.S. in 2024, after its mass-market offerings Model 3 and Model Y.
The company sold&nbsp;<a href="https://www.benzinga.com/25/01/42967593/cybertruck-sales-rise-in-2024-weighed-down-on-tesla-model-s-deliveries-in-us-shows-data" target="_blank" rel="noreferrer noopener">38,965 units in the 12 months through the end of December</a>, significantly higher than the number of Model S or Model X sold in the country.
Tesla made only the foundation series Cybertrucks for the first few months of deliveries. In October, Tesla started selling the <a href="https://www.benzinga.com/25/01/42891397/non-foundation-series-cheaper-cybertrucks-join-tesla-inventory">regular version of Cybertruck </a>priced about $20,000 lower than the foundation series. The foundation series refers to a limited and pricier edition of the Cybertruck with laser-etched foundation series badges and premium accessories.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43650738/nasa-alters-timelines-to-expedite-return-of-astronauts-sunita-williams-butch-wilmore-stranded-at-iss-for-over-8-months">NASA Alters Timelines To Expedite Return Of Astronauts Sunita Williams, Butch Wilmore Stranded At Space Station For Over 8 Months</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Tesla Hikes Discounts On Cybertrucks By 3X To $6000 As It Looks To Clear 2024 Inventory

A suspected gas explosion at the Shin Kong Mitsukoshi shopping mall in Taichung, Taiwan&#8217;s Situn District killed one person and critically injured five others on Wednesday morning, according to local authorities. Emergency responders are continuing rescue efforts and investigating the cause.
The explosion, which occurred on the mall&#8217;s 12th floor at 11:33 a.m. local time, also sent at least 12 people to hospitals, <a href="https://www.taipeitimes.com/News/front/archives/2025/02/13/2003831827">reported</a> Taipei Times.
Reports suggest a possible gas leak while a restaurant was changing a gas canister or ongoing renovations in the food court.
The Taichung Fire Bureau stated that the exact cause remains under investigation.
Police are assisting with evacuations and traffic control as officials warn motorists to avoid the area. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/02/43681236/bitcoin-ethereum-dogecoin-spike-amid-hotter-than-expected-inflation-numbers-eths-decisive-move-above-3000-could-restore-confidence-says-analyst">Bitcoin, Ethereum, Dogecoin Spike Amid Hotter-Than-Expected Inflation Numbers: ETH&#8217;s Decisive Move Above $3,000 Could Restore Confidence, Says Analyst</a></li>
</ul>
Image Via Shutterstock

Global

Taiwan Mall Explosion Kills One, Injures Several — Investigation Underway

Macro Economic Events

Econ #s

Economics

Germany Consumer Price Index (YoY) For January 2.3% Vs. 2.3% Est.; 2.6% Prior

Germany Consumer Price Index (MoM) For January -0.2% Vs. -0.2% Est.; 0.5% Prior

U.K. Trade Balance Non-EU For December -6.10B Vs. -7.19B (Revised) Prior

U.K. Trade Balance For December -17.45B Vs. -18.60B Est.; -18.90B (Revised) Prior

U.K. Monthly Gross Domestic Product 3M/3M Change For December 0.1% Vs. -0.1% (Revised) Prior

U.K. Manufacturing Production (MoM) For December 0.7% Vs. 0.0% Est.; -0.3% Prior

U.K. Industrial Production (MoM) For December 0.5% Vs. 0.2% Est.; -0.5% (Revised) Prior

CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) reported a <a href="https://www.benzinga.com/25/02/43655820/cvs-health-stock-surges-on-better-than-expected-q4-earnings-upbeat-annual-outlook">better-than-expected</a> fourth-quarter earnings result and issued an optimistic guidance for the fiscal year 2025 stemming from the expected recovery in its insurance business — Aetna&#8217;s turnaround.
What Happened: The company provided an initial full-year 2025 guidance for adjusted earnings per share (EPS) in the range of $5.75 to $6 per share, which was over 10% above its 2024 full-year EPS of $5.42.
&#8220;Our initial expectations reflect a meaningful recovery in our Aetna business, particularly in Medicare Advantage, as well as continued growth in Health Services,&#8221; said the executive vice president and CEO, David Joyner during the company&#8217;s earnings call.
The CVS Health Aetna business offers health insurance plans, services, and support to individuals, employers, and communities. Whereas, Aetna Medicare Advantage plans, available through Federal Employees Health Benefits, combine Medicare Parts A and B with extra benefits.
&#8220;Our deliberate approach to our 2025 Medicare Advantage bids, combined with our improved Star ratings will improve margins this year and are part of our ongoing commitment to restore this business to target margins of 3% to 5%,&#8221; added Joyner.
Joyner highlighted his observations and priorities during his first 100 days as CEO. It includes a focus on Aetna turnaround, pharmacy transformation, and leadership team development.
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43683299/cisco-systems-lands-700m-ai-gold-rush-amid-increased-appetite-from-tech-giants-build-more-and-we-will-buy-more-customers-tell-ceo">Cisco Systems Lands $700M AI Gold Rush Amid Increased Appetite From Tech Giants: &#8216;Build More And We Will Buy More,&#8217; Customers Tell CEO</a>
Why It Matters: The company <a href="https://www.benzinga.com/25/02/43655820/cvs-health-stock-surges-on-better-than-expected-q4-earnings-upbeat-annual-outlook">beat fourth-quarter</a> sales expectations and came in at $97.71 billion. However, the adjusted EPS fell to $1.19, from $2.12 in the same period a year ago, exceeding estimates of $0.93. The EPS decline reflects pressure on healthcare benefits due to utilization and lower Medicare Advantage star ratings.
CVS also guided $6.5 billion in cash flow from operations for 2025.
Price Action: CVS Health rose by 14.95% on Wednesday and advanced by 0.36% in after-hours. The exchange-traded fund tracking the S&amp;P 500 index, SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell by 0.32%.
CVS shares have gained 42.97% on a year-to-date basis, whereas it was down by 17.46% over the last year.
The average price target among 28 <a href="https://www.benzinga.com/quote/CVS/analyst-ratings">analysts tracked by Benzinga</a> is $143 with a ‘Buy' rating. The estimates range from $58 to $143 apiece. Recent ratings from Evercore ISI Group, Truist Securities, and Deutsche Bank suggest a $63.67 target, implying a potential upside of 0.34%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/CVS/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="385" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13012654/CVS-ANR-1024x385.png" alt="" class="wp-image-780259" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13012654/CVS-ANR-1024x385.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13012654/CVS-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13012654/CVS-ANR-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13012654/CVS-ANR.png 1065w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43650247/marriotts-digital-penetration-hits-historic-highs-as-bonvoy-app-downloads-soar-adding-31-million-new-members-ceo-says-transformation-enhancing-the-customer-experience" target="_blank" rel="noreferrer noopener">Marriott's Digital Penetration Hits ‘Historic Highs' As Bonvoy App Downloads Soar Adding 31 Million New Members</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Insurance

General

CVS Health Forecasts 10% Earnings Growth For 2025, Citing Aetna's 'Meaningful Recovery'

U.K. Gross Domestic Product (QoQ) Preliminary For Q4 0.1% Vs. -0.1% Est.; 0.0% Prior

U.K. Gross Domestic Product (MoM) For December 0.4% Vs. 0.1% Est.; 0.1% Prior

U.K. Gross Domestic Product (YoY) Preliminary For Q4 1.4% Vs. 1.1% Est.; 1.0% (Revised) Prior

U.K. Business Investment (QoQ) Preliminary For Q4 -3.2% Vs. -0.4% Est.; 1.9% Prior

OncoSec Medical

Comments

OncoSec Medical

News

Latest news for OncoSec Medical (OTC:ONCSQ) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga